|
Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) |
|
Cumberland Pharmaceuticals Inc
CPIX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Cumberland Pharmaceuticals Inc 's sales fell
by -9.92 % in III. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Cumberland Pharmaceuticals Inc net loss increased from $-1 millions, to $-2 millions in III. Quarter 2024,
• More on CPIX's Growth
|
|
Cumberland Pharmaceuticals Inc realized a net loss in trailing twelve months.
Cumberland Pharmaceuticals Inc realized cash reduction of $ -0.07 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.23.
• More on CPIX's Valuation
|
|
|
|
|
Cumberland Pharmaceuticals Inc realized net loss in trailing twelve months.
Cumberland Pharmaceuticals Inc realized cash outflow of $ -0.07per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.23.
Cumberland Pharmaceuticals Inc Price to Book Ratio is at 1.49 lower than Industry Avg. of 68.99. and higher than S&P 500 Avg. of 0.01
• More on CPIX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com